GLP-1-based polyagonists: A promising weight loss alternative to bariatric surgery

FHS
July 29, 2024
3:51 am

Researchers highlight the unprecedented success of GLP-1-based multi-receptor drugs in achieving substantial weight loss and improved health outcomes, potentially replacing bariatric surgery for obesity treatment.

Neurodivergent children face higher risk of chronic disabling fatigue by 18, study finds

Neurodivergent traits in childhood double the risk of chronic disabling fatigue by age 18, with inflammation playing a significant mediating role. This highlights the importance

July 31, 2024

Make the Diagnosis: It’s a Painless Pink Nodule. How Bad Could It Be?

Presentation A 49-year-old woman visited her doctor concerned about a lesion that developed over her right toe within the last 4 weeks. It was painless

August 17, 2023

American Medical Association Releases Language of First New Current Procedural Terminology Code for Psychedelic Therapies | Psychedelic Invest

COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that the American Medical

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.